Related Experiment Videos
[Clinical application of allogeneic tendon].
Wanxiang Deng1, Hurui Zhao, Hui Dong
1Microsurgery Center, 474th Hospital of PLA, Urumqi Xinjiang 830011, P R China.
Summary
Ultra-deep-low-temperature allogeneic tendon grafts show excellent clinical results for tendon repair and ligament rupture, with a 92.71% success rate and no observed rejection or rupture. This method offers a viable alternative to autografts.
Area of Science:
- Orthopedic surgery
- Tissue engineering
- Regenerative medicine
Context:
- Tendon injuries and ligament ruptures often require reconstructive procedures.
- Autografts, while effective, have limitations such as donor site morbidity.
- Allogeneic tissues offer a potential alternative, but their clinical application requires careful handling and preservation.
Purpose:
- To evaluate the clinical efficacy and safety of allogeneic tendons preserved using an ultra-deep-low-temperature method for repairing tendon ruptures and ligament defects.
- To assess the functional outcomes and complication rates associated with this allograft technique.
Summary:
- A retrospective study involved 96 patients undergoing repair of tendon ruptures or ligament defects using ultra-deep-low-temperature preserved allogeneic tendon grafts between March 1995 and June 2002.
- Grafts were used for various injuries, including hand flexor/extensor tendons, coracoclavicular ligaments, cruciate ligaments, calcaneus tendons, and foot extensor tendons.
- Postoperative management included early functional exercise, with secondary release for adhesions. Follow-up averaged 3.4 years.
Impact:
- The study demonstrates that ultra-deep-low-temperature preserved allogeneic tendons are a safe and effective option for clinical tendon and ligament reconstruction.
- Achieved a high success rate (92.71%) with no instances of graft rejection or rupture, suggesting comparable healing and functional outcomes to autografts.
- This technique expands the options for reconstructive surgery, potentially reducing donor site morbidity associated with autologous tissue harvesting.